Rinri Therapeutics
PrivateLast Round
Grant
Oct 2, 2025
Total Funding Raised
$31.74M
Company Overview
Rinri Therapeutics operates in Healthcare & Life Sciences and is based in Sheffield. Its latest recorded funding round was a Grant round in October 2025.
Rinri Therapeutics is a biotechnology company developing first-in-class regenerative cell therapies to restore hearing by repairing damaged sensory cells in the inner ear.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rinri Therapeutics Comparables
Compare Rinri Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CamGene Therapeutics | 83% | |
| Salubritas Therapeutics | 82% | |
| Frequency Therapeutics | 78% |
For institutional investors. Book with your work email.
Rinri Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Grant | May 13, 2021 | ||||
| Seed | May 20, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rinri Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Grant, Series A, Seed |
| Pioneer Group | Series A |
| British Business Bank | Grant |
| UCB Ventures | Grant, Seed |
| Innovate UK | Grant |
| J.P. Morgan Asset Management | Grant |
| Boehringer Ingelheim Venture Fund | Grant, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2025
$1M grant received.
- Oct 2, 2025
Attended the 2nd Annual Life Sciences Innovation Summit on October 2, 2025.
For institutional investors. Book with your work email.
Rinri Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rinri Therapeutics's valuation, stock price, and market status.
Is Rinri Therapeutics a public or private company?
Rinri Therapeutics is a private company.
What is the current stock price of Rinri Therapeutics?
Rinri Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rinri Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rinri Therapeutics worth (valuation)?
Valuation information for Rinri Therapeutics is not publicly available.
Can I buy Rinri Therapeutics stock?
Rinri Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rinri Therapeutics's last funding round?
Rinri Therapeutics's most recent funding round was Grant on October 2, 2025.
Who are the main investors in Rinri Therapeutics?
Key investors in Rinri Therapeutics include UCB Ventures, UCB Ventures, Innovate UK, Boehringer Ingelheim Venture Fund.
Will Rinri Therapeutics IPO soon?
No public IPO plans have been announced for Rinri Therapeutics.
How can I track Rinri Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rinri Therapeutics's shares on secondary markets.